Please login to the form below

Not currently logged in
Email:
Password:

SK Life Science

This page shows the latest SK Life Science news and features for those working in and with pharma, biotech and healthcare.

FDA clears SK Life Science’s anti-epileptic drug Xcopri

FDA clears SK Life Science’s anti-epileptic drug Xcopri

Significantly reduced the frequency of seizures at all doses studied. Korea-based SK Life Sciences has scored approval from the FDA in the US for its anti-epileptic drug Xcopri, as ... said Jeong Woo Cho, president and CEO of SK Biopharmaceuticals and SK

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics